BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 22626471)

  • 21. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.
    Zhu S; Guo Y; Zhang X; Liu H; Yin M; Chen X; Peng C
    Cancer Lett; 2021 Apr; 503():240-248. PubMed ID: 33246091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
    Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
    J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depletion of PKM2 leads to impaired glycolysis and cell death in 2-demethoxy-2,3-ethylenediamino hypocrellin B-photoinduced A549 cells.
    Zhou Z; Liu Y; Qin M; Sheng W; Wang X; Li Z; Zhong R
    J Photochem Photobiol B; 2014 May; 134():1-8. PubMed ID: 24792468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma.
    Zhao X; Zhao L; Yang H; Li J; Min X; Yang F; Liu J; Huang G
    J Biol Chem; 2018 Apr; 293(17):6623-6634. PubMed ID: 29514980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PKM2, a potential target for regulating cancer.
    Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
    Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
    Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
    Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
    Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
    Amin S; Yang P; Li Z
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of Evidence for PKM2 Protein Kinase Activity.
    Hosios AM; Fiske BP; Gui DY; Vander Heiden MG
    Mol Cell; 2015 Sep; 59(5):850-7. PubMed ID: 26300261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism.
    Wang HJ; Hsieh YJ; Cheng WC; Lin CP; Lin YS; Yang SF; Chen CC; Izumiya Y; Yu JS; Kung HJ; Wang WC
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):279-84. PubMed ID: 24344305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-625-5p/PKM2 negatively regulates melanoma glycolysis state.
    Zhang H; Feng C; Zhang M; Zeng A; Si L; Yu N; Bai M
    J Cell Biochem; 2019 Mar; 120(3):2964-2972. PubMed ID: 30500994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyruvate kinase M2: A simple molecule with complex functions.
    Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A
    Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
    Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
    Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase.
    Mor I; Carlessi R; Ast T; Feinstein E; Kimchi A
    Oncogene; 2012 Feb; 31(6):683-93. PubMed ID: 21725354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect.
    Sun Y; Zhao X; Zhou Y; Hu Y
    Oncol Rep; 2012 Oct; 28(4):1346-52. PubMed ID: 22895557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The multifaceted regulation and functions of PKM2 in tumor progression.
    Li Z; Yang P; Li Z
    Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,3'4,4',5-Pentachlorobiphenyl induces hepatocellular carcinoma cell proliferation through pyruvate kinase M2-dependent glycolysis.
    Liang W; Zhang Y; Song L; Li Z
    Toxicol Lett; 2019 Oct; 313():108-119. PubMed ID: 31251971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderate DNA damage promotes metabolic flux into PPP via PKM2 Y-105 phosphorylation: a feature that favours cancer cells.
    Kumar B; Bamezai RN
    Mol Biol Rep; 2015 Aug; 42(8):1317-21. PubMed ID: 25840825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma.
    Xiaoyu H; Yiru Y; Shuisheng S; Keyan C; Zixing Y; Shanglin C; Yuan W; Dongming C; Wangliang Z; Xudong B; Jie M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818780063. PubMed ID: 29916308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.